Cv Sciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cv Sciences Inc's ROI in the second quarter of 2026?
Cv Sciences Inc recorded a cumulative net loss of $-2 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -89.89%.

Within the Healthcare sector 578 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3806 to 3931.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-1.26 %	7.27 %	3.25 %	-10.07 %	-22.46 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	2	3	2	2	2
Return On Investment (TTM)	-89.89 %	-60.74 %	-40.72 %	-63.8 %	-68.67 %
CVSI's Overall Ranking	# 3931	# 3806	# 2756	# 3180	#
Seq. Investment Change TTM	-9.15 %	4.4 %	1.55 %	2.51 %	-1.3 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-2	-1	-1	-1	-2

CVSI Company Profile >> Back to CVSI Roi Comparisons >> See Annual CVSI Return On Investment

Return On Investment CVSI's Ranking
Within:	No.
Industry	# 259
Sector	# 579
Overall	# 3931

Return On Investment Statistics
High	Average	Low
76.03 %	-57.42 %	-525.71 %
(Dec 31 2023)		(Sep 30 2022)

Financial Statements
Cv Sciences Inc's II. Quarter Investments	$ 2 Millions	CVSI's Balance sheet
Cv Sciences Inc's II. Quarter Income	$ -1 Millions	Quarterly CVSI's Income Statement
CVSI's Income by Division		See CVSI's Income by Division

CVSI Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	2	2	3	-1	4
Y / Y Investment Growth	7.92 %	-39.56 %	-	-	-77.87 %
Net Income in Millions	-1	-2	3	-9	-16
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-48.83 %	-131.68 %	103.13 %	-	-431.46 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CVSI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CVSI's Competitors
Subscribers only: Roi for Cv Sciences Inc's Suppliers
Subscribers only: Return On Investment for CVSI's Customers

Other Ratios
CVSI's Roa	CVSI's Inventory Turnover Ratio	CVSI's Growth Rates	CVSI's Dividend Statistics
	CVSI's Profitability Ratios	CVSI's Asset Turnover Ratio	CVSI's Dividend Growth
CVSI's Roe	CVSI's Valuation Ratios	CVSI's Financial Strength Ratios	CVSI's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-12T06:18:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.